Uganda Receives First 19,200 Doses of Long-Acting HIV Prevention Drug Lenacapavir as Kenya Begins Rollout

Uganda has received its first 19,200 doses of Lenacapavir, a groundbreaking long-acting drug designed to prevent HIV. This shipment marks a major milestone in the region's decades-long fight against the epidemic.

Previous Article

Lupita Nyong’o Shares Harrowing Uterine Fibroid Health Update

Health

MOSES SAGWE3mon ago

Next Article

Global Trends and Rising Risks in Cosmetic Surgery

Health

Gabriel Sironka4mon ago

NCCK Breaks Silence on Owuor’s HIV/AIDS ‘Miracle’ Healing Claims

Entertainment

moses sagwe5mon ago

Pastor T Mwangi’s Viral HIV Testimony Ignites Debate

Entertainment

stephen atila4mon ago